U.S. 'unprepared for' resurgence of MDR-TB, Wall Street Journal reports

"Multidrug-resistant [tuberculosis (TB)] is at epidemic proportions in some parts of the world -- a growing problem the U.S. is surprisingly unprepared for," the Wall Street Journal reports. Noting "[t]he U.S. beat back multidrug-resistant tuberculosis [MDR-TB] in the 1990s," the newspaper continues, "Today, however, a new threat is emerging as drug resistance worsens abroad and far more dangerous strains develop and spread, including some that are all but untreatable with standard drugs." The Wall Street Journal examines reasons behind a resurgence of MDR-TB in the U.S., treatment and control efforts, and how "funding and expertise are in decline" (12/19).